Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Intravenous Anesthetic market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Intravenous Anesthetic market segmented into
Tetrazolium
Ketamine
Sodium Oxybate
Others
Based on the end-use, the global Intravenous Anesthetic market classified into
Hospital Use
Clinic Use
Other
Based on geography, the global Intravenous Anesthetic market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
AstraZeneca
Fresenius-Kabi
BbVie Laboratories
Baxter Healthcare
Braun
Maruishi
Piramal Healthcare
Hikma Pharmaceuticals
Mylan
Nhwa
Lunan
Hengrui
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INTRAVENOUS ANESTHETIC INDUSTRY
2.1 Summary about Intravenous Anesthetic Industry
2.2 Intravenous Anesthetic Market Trends
2.2.1 Intravenous Anesthetic Production & Consumption Trends
2.2.2 Intravenous Anesthetic Demand Structure Trends
2.3 Intravenous Anesthetic Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Tetrazolium
4.2.2 Ketamine
4.2.3 Sodium Oxybate
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital Use
4.3.2 Clinic Use
4.3.3 Other
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Tetrazolium
5.2.2 Ketamine
5.2.3 Sodium Oxybate
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital Use
5.3.2 Clinic Use
5.3.3 Other
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Tetrazolium
6.2.2 Ketamine
6.2.3 Sodium Oxybate
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital Use
6.3.2 Clinic Use
6.3.3 Other
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Tetrazolium
7.2.2 Ketamine
7.2.3 Sodium Oxybate
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital Use
7.3.2 Clinic Use
7.3.3 Other
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Tetrazolium
8.2.2 Ketamine
8.2.3 Sodium Oxybate
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital Use
8.3.2 Clinic Use
8.3.3 Other
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Tetrazolium
9.2.2 Ketamine
9.2.3 Sodium Oxybate
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital Use
9.3.2 Clinic Use
9.3.3 Other
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 AstraZeneca
10.1.2 Fresenius-Kabi
10.1.3 BbVie Laboratories
10.1.4 Baxter Healthcare
10.1.5 Braun
10.1.6 Maruishi
10.1.7 Piramal Healthcare
10.1.8 Hikma Pharmaceuticals
10.1.9 Mylan
10.1.10 Nhwa
10.1.11 Lunan
10.1.12 Hengrui
10.2 Intravenous Anesthetic Sales Date of Major Players (2017-2020e)
10.2.1 AstraZeneca
10.2.2 Fresenius-Kabi
10.2.3 BbVie Laboratories
10.2.4 Baxter Healthcare
10.2.5 Braun
10.2.6 Maruishi
10.2.7 Piramal Healthcare
10.2.8 Hikma Pharmaceuticals
10.2.9 Mylan
10.2.10 Nhwa
10.2.11 Lunan
10.2.12 Hengrui
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
1.Table Intravenous Anesthetic Product Type Overview
2.Table Intravenous Anesthetic Product Type Market Share List
3.Table Intravenous Anesthetic Product Type of Major Players
4.Table Brief Introduction of AstraZeneca
5.Table Brief Introduction of Fresenius-Kabi
6.Table Brief Introduction of BbVie Laboratories
7.Table Brief Introduction of Baxter Healthcare
8.Table Brief Introduction of Braun
9.Table Brief Introduction of Maruishi
10.Table Brief Introduction of Piramal Healthcare
11.Table Brief Introduction of Hikma Pharmaceuticals
12.Table Brief Introduction of Mylan
13.Table Brief Introduction of Nhwa
14.Table Brief Introduction of Lunan
15.Table Brief Introduction of Hengrui
16.Table Products & Services of AstraZeneca
17.Table Products & Services of Fresenius-Kabi
18.Table Products & Services of BbVie Laboratories
19.Table Products & Services of Baxter Healthcare
20.Table Products & Services of Braun
21.Table Products & Services of Maruishi
22.Table Products & Services of Piramal Healthcare
23.Table Products & Services of Hikma Pharmaceuticals
24.Table Products & Services of Mylan
25.Table Products & Services of Nhwa
26.Table Products & Services of Lunan
27.Table Products & Services of Hengrui
28.Table Market Distribution of Major Players
29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
31.Table Global Intravenous Anesthetic Market Forecast (Million USD) by Region 2021f-2026f
32.Table Global Intravenous Anesthetic Market Forecast (Million USD) Share by Region 2021f-2026f
33.Table Global Intravenous Anesthetic Market Forecast (Million USD) by Demand 2021f-2026f
34.Table Global Intravenous Anesthetic Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Intravenous Anesthetic Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Intravenous Anesthetic Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Intravenous Anesthetic Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Intravenous Anesthetic Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Intravenous Anesthetic Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Intravenous Anesthetic Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Intravenous Anesthetic Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Tetrazolium Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Ketamine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Sodium Oxybate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Hospital Use Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Clinic Use Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Other Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Tetrazolium Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Ketamine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Sodium Oxybate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Hospital Use Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Clinic Use Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Other Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Tetrazolium Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Ketamine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Sodium Oxybate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Hospital Use Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Clinic Use Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Other Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Tetrazolium Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Ketamine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Sodium Oxybate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Hospital Use Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Clinic Use Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Other Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Tetrazolium Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Ketamine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Sodium Oxybate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Hospital Use Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Clinic Use Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Other Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Tetrazolium Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Ketamine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Sodium Oxybate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Hospital Use Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
75.Figure Clinic Use Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2
